Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Phase I Reactions: Reductive Reactions

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...

Oxidations of Aldehydes and Ketones to Carboxylic Acids

Oxidations of Aldehydes and Ketones to Carboxylic Acids

Oxidation of aldehydes and ketones results in the formation of carboxylic acids. Aldehydes, bearing hydrogen next to the carbonyl group, are easily oxidized compared to ketones. This is because an aldehydic proton can easily be abstracted during oxidation.
Aldehydes readily undergo oxidation in strong oxidizing agents such as potassium permanganate and chromic acid. The oxidation can also be carried out using mild oxidizing agents such as silver oxide. In fact, aldehydes can be easily oxidized...

Alcohols from Carbonyl Compounds: Reduction

Alcohols from Carbonyl Compounds: Reduction

Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...

Preparation of Aldehydes and Ketones from Carboxylic Acid Derivatives

Preparation of Aldehydes and Ketones from Carboxylic Acid Derivatives

Aldehydes are more reactive than carboxylic acids and hence, can get over-reduced to alcohol in the presence of strong reducing agents. Therefore, carboxylic acids are inefficient in preparing aldehydes using LAH.
Carboxylic acid derivatives like acid chlorides and esters are more easily reducible than the corresponding acids. The derivatives reduce in the presence of mild reducing agents to give aldehydes. Aldehydes can also be prepared by Rosenmund reduction, that is, the reduction of...

Adrenergic Agonists: Therapeutic Uses

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Common human ALDH1B1 and ALDH2 variants increase neuroinflammatory response to a single ethanol dose in mice.

Science advances·2026

Same author

Integrating genetic and lifestyle determinants in a risk prediction model for esophageal squamous cell carcinoma in Taiwan.

Scientific reports·2026

Same author

Racial and geographic differences of opioid overdose deaths involving additional drugs of abuse: analysis of US mortality database.

British journal of anaesthesia·2026

Same author

Increased susceptibility to 4-HNE-induced toxicity and impaired development in a model of ALDH4A1-deficient pediatric epilepsy carrying the S352L variant.

Communications biology·2026

Same author

Breath-based Propofol Pharmacometabolomics: Comment.

Anesthesiology·2026

Same author

Site-Specific Blockade of LPA-TRPV1 Interaction at K710 Residue Influences on Myocardial Ischemia/Reperfusion Injury in Ex Vivo Mouse Hearts.

Anesthesia and analgesia·2026

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Reactive aldehydes: an initial path to develop precision medicine for pain control.

Vanessa O Zambelli¹, Che-Hong Chen¹, Eric R Gross¹

¹1 Laboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil ; 2 Department of Chemical and Systems Biology, 3 Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Annals of Translational Medicine

|November 26, 2015

Summary

This summary is machine-generated.

Reactive aldehydes contribute to pain sensation. Mitochondrial aldehyde dehydrogenase 2 (ALDH2) metabolism of these aldehydes offers a target for pain management, especially for individuals with the ALDH2*2 variant.

Keywords:

ALDH2*2 Reactive aldehydes aldehyde dehydrogenase 2 (ALDH2)pain precision health

More Related Videos

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Published on: June 13, 2025

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

Related Experiment Videos

Last Updated: Mar 29, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Published on: June 13, 2025

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

Area of Science:

Biochemistry
Pain research
Pharmacology

Background:

Opioid-related risks necessitate novel pain treatment targets.
Reactive aldehydes are implicated in pain signaling pathways.
Mitochondrial aldehyde dehydrogenase 2 (ALDH2) plays a role in aldehyde metabolism.

Purpose of the Study:

To explore the role of reactive aldehydes in pain.
To investigate the function of ALDH2 in regulating inflammatory pain.
To discuss the clinical implications of ALDH2 variants in pain management.

Main Methods:

Literature review and discussion in response to an editorial.
Analysis of reactive aldehyde production and metabolism in pain.
Examination of ALDH2 enzyme activity and its impact on pain.

Main Results:

Reactive aldehyde production can initiate pain signaling.
ALDH2 efficiently metabolizes reactive aldehydes, mitigating inflammatory pain.
Inefficient metabolism due to ALDH2*2 variant affects approximately 540 million people.

Conclusions:

Targeting ALDH2 offers a potential therapeutic strategy for pain control.
ALDH2-targeted therapeutics could lead to precision medicine for pain.
Understanding ALDH2's role is crucial for developing non-addictive pain treatments.